Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse

Bioconjugate Chemistry

Volumn 25, Issue 3, 2014, Pages 593-600

  Collins, Karen C ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; IMMUNE SYSTEM; NICOTINE;

ANTIBODY AFFINITY; ANTIBODY CONCENTRATION; CLUSTERINGS; DIGLYCINE; DRUG OF ABUSE; IMMUNE RESPONSE; MODULARS; SYNTHESISED; TRIVALENTS;

VACCINES;

ANTIBODY; DIGLYCINE; HAPTEN; NICOTINE; NICOTINE VACCINE; VACCINE; STREET DRUG;

ANIMAL EXPERIMENT; ARTICLE; CROSS LINKING; DRUG ABUSE; DRUG STRUCTURE; IMMUNE RESPONSE; IMMUNOLOGY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; ANIMAL; ANTIBODY AFFINITY; CHEMISTRY; CONFORMATION; SUBSTANCE ABUSE; SYNTHESIS;

ANIMALS; ANTIBODY AFFINITY; HAPTENS; MICE; MOLECULAR CONFORMATION; NICOTINE; STREET DRUGS; SUBSTANCE ABUSE DETECTION; VACCINES;

EID: 84896529952     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc500016k     Document Type: Article

References (34)

1. World Health Organization, WHO Report on the Global TobaccoEpidemic, (2011): Warning about the Dangers of Tobacco.
2. Hatsukami, D. K., Stead, L. F., and Gupta, P. C. (2008) Tobacco addiction The Lancet 371, 2027-2038
3. Cornuz, J., Zwahlen, S., Jungi, W. F., Osterwalder, J., Klingler, K., van Melle, G., Bangala, Y., Guessous, I., Müller, P., Willers, J., Maurer, P., Bachmann, M. F., and Cerny, T. (2008) A vaccine against nicotine for smoking cessation: a randomized controlled trial PLoS ONE 3, e2547
4. Hatsukami, D. K., Jorenby, D. E., Gonzales, D., Rigotti, N. A., Glover, E. D., Oncken, C. A., Tashkin, D. P., Reus, V. I., Akhavain, R. C., Fahim, R. E. F., Kessler, P. D., Niknian, M., Kalnik, M. W., and Rennard, S. I. (2011) Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic Clin. Pharmacol. Ther. 89, 392-399
5. Janeway, C. A., Travers, P., Walport, M., and Shlomchik, M. J. (2001) Chapter 9. The Humoral Immune Response; B-cell Activation by armed helper T cells, in Immunobiology: The Immune System in Health and Disease, Garland Science, New York.
6. Marco, M.-P., Gee, S., and Hammock, B. D. (1995) Immunochemical techniques for environmental analysis II. Antibody production and immunoassay development TrAC-Trends Anal. Chem. 14, 415-425
7. Dintzis, H. M., Dintzis, R. Z., and Vogelstein, B. (1976) Molecular determinants of immunogenicity: the immunon model of immune response Proc. Natl. Acad. Sci. U.S.A. 73, 3671-3675
8. Peri, F. (2013) Clustered carbohydrates in synthetic vaccines Chem. Soc. Rev. 42, 4543-4556
9. Buskas, T., Thompson, P., and Boons, G.-J. (2009) Immunotherapy for cancer: synthetic carbohydrate-based vaccines Chem. Commun. 5335-5349
10. Dumy, P., Eggleston, I. M., Cervigni, S., Sila, U., Sun, X., and Mutter, M. (1995) A convenient synthesis of cyclic peptides as regioselectively addressable functionalized templates (RAFT) Tetrahedron Lett. 36, 1255-1258
11. Grigalevicius, S., Chierici, S., Renaudet, O., Lo-Man, R., Dériaud, E., Leclerc, C., and Dumy, P. (2005) Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines Bioconjugate Chem. 16, 1149-1159
12. Tam, J. P. (1988) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system Proc. Natl. Acad. Sci. U.S.A. 85, 5409-5413
13. Duryee, M. J., Bevins, R. A., Reichel, C. M., Murray, J. E., Dong, Y., Thiele, G. M., and Sanderson, S. D. (2009) Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines Vaccine 27, 2981-2988
14. Moreno, A. Y., Azar, M. R., Warren, N. A., Dickerson, T. J., Koob, G. F., and Janda, K. D. (2010) A critical evaluation of a nicotine vaccine within a self-administration behavioral model Mol. Pharmaceutics 7, 431-441
15. Janda, K. D. (2011) Nicotine haptens, immunoconjugates and their uses. WO 031327 (A2).
16. Lockner, J. W., Ho, S. O., McCague, K. C., Chiang, S. M., Do, T. Q., Fujii, G., and Janda, K. D. (2013) Enhancing nicotine vaccine immunogenicity with liposomes Bioorg. Med. Chem. Lett. 23, 975-978
17. Pryde, D. C., Jones, L. H., Gervais, D. P., Stead, D. R., Blakemore, D. C., Selby, M. D., Brown, A. D., Coe, J. W., Badland, M., Beal, D. M., Glen, R., Wharton, Y., Miller, G. J., White, P., Zhang, N., Benoit, M., Robertson, K., Merson, J. R., Davis, H. L., and McCluskie, M. J. (2013) Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice PLoS ONE 8, e76557
18. Zapotoczny, S., Biedroń, R., Marcinkiewicz, J., and Nowakowska, M. (2012) Atomic force microscopy-based molecular studies on the recognition of immunogenic chlorinated ovalbumin by macrophage receptors J. Mol. Recognit. 25, 82-88
19. Boyaka, P. N., Ohmura, M., Fujihashi, K., Koga, T., Yamamoto, M., Kweon, M.-N., Takeda, Y., Jackson, R. J., Kiyono, H., Yuki, Y., and McGhee, J. R. (2003) Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit J. Immunol. 170, 454-462
20. Fleck, C., Franzmann, E., Claes, D., Rickert, A., and Maison, W. (2013) Synthesis of functionalized adamantane derivatives: (3 + 1)-scaffolds for applications in medicinal and material chemistry Synthesis 45, 1452-1461
21. Lamoureux, G. and Artavia, G. (2010) Use of the adamantane structure in medicinal chemistry Curr. Med. Chem. 17, 2967-2978
22. Still, W. C., Kahn, M., and Mitra, A. (1978) Rapid chromatographic technique for preparative separations with moderate resolution J. Org. Chem. 43, 2923-2925
23. Cushman, M. and Castagnoli, N. (1972) Synthesis of trans-3′- methylnicotine J. Org. Chem. 37, 1268-1271
24. Delimarskii, R. E., Rodionov, V. N., and Yurchenko, A. G. (1988) Preparative synthesis of 1,3,5-tribromoadamantane Ukr. Khim. Zh. 54, 437-438
25. Baum, K., Archibald, T. G., and Malik, A. A. (1991) Ethynyl adamantane derivatives and methods of polymerization thereof. U. S. Patent 5017734 (A).
26. Malik, A. A., Archibald, T. G., Baum, K., and Unroe, M. R. (1992) Thermally stable polymers based on acetylene-terminated adamantanes J. Polym. Sci., Part A: Polym. Chem. 30, 1747-1754
27. Maison, W., Frangioni, J. V., and Pannier, N. (2004) Synthesis of rigid multivalent scaffolds based on adamantane Org. Lett. 6, 4567-4569
28. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent J. Biol. Chem. 193, 265-275
29. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using bicinchoninic acid Anal. Biochem. 150, 76-85
30. Wengatz, I., Schmid, R. D., Kreißig, S., Wittmann, C., Hock, B., Ingendoh, A., and Hillenkamp, F. (1992) Determination of the hapten density of immuno-conjugates by matrix-assisted UV laser desorption/ionization mass spectrometry Anal. Lett. 25, 1983-1997
31. Müller, R. (1983) Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay Methods Enzymol. 92, 589-601
32. Pravetoni, M., Keyler, D. E., Pidaparthi, R. R., Carroll, F. I., Runyon, S. P., Murtaugh, M. P., Earley, C. A., and Pentel, P. R. (2012) Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities Biochem. Pharmacol. 83, 543-550
33. Pravetoni, M., Naour, M. L., Harmon, T. M., Tucker, A. M., Portoghese, P. S., and Pentel, P. R. (2012) An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia J. Pharmacol. Exp. Ther. 341, 225-232
34. Cornish, K. E., Harris, A. C., LeSage, M. G., Keyler, D. E., Burroughs, D., Earley, C., and Pentel, P. R. (2011) Combined active and passive immunization against nicotine: Minimizing monoclonal antibody requirements using a target antibody concentration strategy Int. Immunopharmacol. 11, 1809-1815